Hilfe & Kontakt

Autism and the Human Gut Flora

Von: pautrey (rpautrey2@gmail.com) [Profil]
Datum: 05.06.2010 18:20
Message-ID: <1c9e1bc6-e3be-4cb5-bb8e-2f79b77d10fc@j8g2000yqd.googlegroups.com>
Newsgroup: alt.healthmisc.kids.health sci.med.psychobiology
The Environmental Illness Resource

Autism and the Human Gut Flora

Articles - Autism Articles

by Dr. Max Bingham

Food Microbial Sciences Unit, Science and Technology Centre, Earley
Gate, University of Reading, Whiteknights Road, Reading, Berkshire,


Previous research into autism has raised the possibility that a link
exists between the disorder and the human gut microflora. Research has
remained limited due to the unwillingness of the orthodox medical
establishment to adopt treatments suggested by this research. This
short review aims to summarise the research completed to date and
evaluate the relevance of a link between autism and a possible
imbalance in the human gut microflora. It appears that yeasts (Candida
species in particular) and clostridia may play an important role in
the development of autistic symptoms. It is suggested that the control
of the growth of these species may reduce the severity of autistic
symptoms but is unlikely to offer a cure.


Previous research into autism has raised the possibility that a link
exists between the disorder and the human gut microflora. However the
relevance of this to sufferers of Autism has remained somewhat un-
researched. As a consequence, it appears that the treatments suggested
previously have remained unused and regarded by the orthodox medical
establishment as irrelevant. This short review will consider the
limited research completed to date.


The term autism is usually associated with the syndrome first
described by Kanner (1943). In more recent years specific criteria
have been set out to aid in the diagnosis of the disorder (Shaw et al,
1999). Autism typically develops early in childhood, however
causality, explanation and treatment are often hotly debated. Symptoms
can include (but not necessarily), hyperactivity, loss of eye contact,
decreased vocalisation (i.e. loss of language), stereotypical
behaviours, poor academic performance and other similar social
deficits. Other similar disorders exist. These include Asperger
Syndrome, Attention Deficit Hyperactivity Disorder (ADHD), Pervasive
developmental disorder (PDD) and many others, where symptoms are
similar to Autism but specific differences are demonstrated.

Yeast metabolites in the Urine of Autistic Children

Yeasts constitute only a very small proportion of the population of
the gut (Holzapfel et al, 1998) under normal conditions – possibly
kept from growing via competition from bacterial species and certain
immune functions. However, Shaw et al (1999) has proposed that Autism
(or at least many of the symptoms) may be a consequence of an
overgrowth of candida species and a selective IgA deficiency.
Following treatment with antifungal drugs and a gluten and casein free
diet, a child rated as having severe autism improved such an amount as
to be classed as a higher functioning individual with autism.*

It has been shown previously that children exhibiting autistic
features have increased excretion of arabinose and the analogs of
Krebs Cycle metabolites (including tartaric acid) (Shaw, Kassen &
Chaves, 1995). Using Gas Chromatography/Mass Spectrometry (GC/MS) to
test for urinary metabolites, it was found that the children had
extremely high values of tartaric acid. The only source of tartaric
acid is yeast (Shaw, 1999). Many reports have suggested that the onset
of autism may be related to the occurrence in children of otitis media
(Kontstantareas & Homatidis, 1987). It is common to treat otitis media
with some sort of broad-spectrum antibiotic. Intestinal overgrowth of
yeast and certain anaerobic bacteria are a well documented outcome of
the administration of broad spectrum antibiotics (Kennedy & Volz,
1983; Danna et al, 1991; Ostfield et al, 1977; Kinsman et al, 1989;
Van der Waaij, 1987; Samsonis et al, 1993, 1994a,b).

To evaluate this, it is known that Shaw (1999, 1996) has used GC/MS to
test the urinary content of metabolites following the administration
of Nystatin, an antifungal drug. Accordingly it was found that urinary
tartaric acid declined to zero after about 60 days. When the Nystatin
dose was cut to half, levels appeared to rise. Associated with this
was seen an improvement in eye contact, a reduction in hyperactivity
and an improvement in sleep patterns. It is unclear as to the method
used, however these are interesting results. In other work, Shaw
(1999) has evaluated the progress of the Herxheimer reaction of yeast
die off. Values for the microbial metabolites described above
increased dramatically during the first three days and began to
normalise near day four. It is unclear as to the relevance of the
point that many children take antibiotics for a whole series of
illnesses, but do not develop autism.

Gupta et al (1996) have studied some possible modulating factors in
Autism. These include immunodeficiencies and probable differences in
biochemical detoxication factors which appear to be very common in
autism,. It has been estimated that a high percentage of autisitic
children have a significant immune dysfunction that may include
myeloperoxidase deficiency, a genetic deficiency that impairs the
action of white blood cells on yeast cells, IgA deficiency, complement
C4b deficiency, IgG deficiency or IgG subclass deficiency (Gupta et
al, 1996). In the above study, a complete remission of autisitic
symptoms was achieved by infusions of gamma globulin in one case. Shaw
(1999) has suggested that it seems increasingly likely that the immune
system takes an inventory of bacteria and yeast cells present in the
gut soon after birth. This inventory is performed by CD5+ B-cells.
These cells may play a role in regulating the secretion of IgA, the
antibody class that is secreted into the intestinal tract and which
may select which microorganisms are tolerated in the gut. Continuing,
it is suggested that the eradication of the normal gut flora when
antibiotics are administered repeatedly during infancy may cause the
CD5+ cells to reject normal cells and award immune tolerance to
species that potentially could cause harm. Either antibiotic use in
infancy or yeast infection of the mother during pregnancy may result
in later tolerance to yeast. This would possibly extend any remission
from symptoms induced by methods of treatment suggested for autism.

Yeast and Tartaric Acid Toxicity

Shaw, Kassen & Chaves (1995) noted in their initial study of the two
brothers with autism, that in addition to their autistic
characteristics, they exhibited severe muscle weakness. Both of these
brothers excreted large amounts of tartaric acid in their urine. It is
known that tartaric acid is an analog of malic acid. Malic acid is a
key intermediate in the Krebs cycle which is responsible for the
extraction of most of the energy from food substrates. Tartaric acid
is presumably seen as toxic since it would inhibit this pathway and
limit energy production. This may be the reason for the muscle
weakness seen in the two autistic brothers. It has also been shown
that Candida albicans produce gliotoxins (Shah and Larsen, 1991 and
1992) and immunotoxins (Podzorski et al, 1989; Witken, 1985), which
may further impair the immune system. This would have relevance in
terms of promoting yeast growth and increasing the chances of
additional infections from bacteria leading to antibiotic usage again.

Arabinose, Yeast and Autism

Shaw, Kassen & Chaves (1995), also identified high levels of arabinose
in the urine of the autistic children. The exact biochemical role of
arabinose is unknown, but a closely related yeast alcohol, arabitol
has been used as a biochemical indicator of invasive candidiasis
(Kiehn et al, 1979; Wong et al, 1990, Roboz & Katz, 1992). It is
thought that arabitol produced by the yeast in the gut is absorbed
into the portal circulation and then converted to arabinose by the
liver. Elevated protein-bound arabinose has been found in the serum
glycoproteins of schizophrenics (Varma & Hoshino, 1980) and in
children with conduct disorders (Varma et al, 1983).

Arabinose reacts with the epsilon amino group of lysine in a wide
variety of proteins and may then form cross-links with arginine
residues in an adjoining protein (Sell & Monnier, 1989). Arabinose has
therefore been implicated in protein modification via cross-linking
the proteins and altering both biological structures and functions of
a wide variety of proteins. Shaw et al (1999) has proposed that this
may include proteins involved in the interconnection of neurons.
Decreased clinical symptoms of autism after antifungal treatment might
be due to decreased arabinose and pentosidine formation (cross-linked
proteins described above). This would result in fewer random neural
connections and increased numbers of neural connections that are
oriented to the child’s environment. The influence of a number of
vitamins on candida activity and the operation of many metabolites of
candida has been discussed (Mahler & Cordes, 1966). It is commonly
found that children with autism experience improved symptoms following
removal of gluten and casein from the diet (Shattock et al 1990, 1991,
1996, 1997; Reichelt et al, 1981, 1986; Knivsberg et al, 1990). It is
unclear whether there is a link with arabinose and pentosidine
formation, however given the wide distribution of these proteins in
foods, there may be a relevant process involved with respect to
autistic symptoms. Research into this may be useful.

Clostridia and Autism

Bolte (1998) outlined the possibility of a subacute, chronic tetanus
infection of the gut as the underlying cause for symptoms of autism
observed in some individuals. Here it is postulated that a percentage
of individuals with autism have a history of extensive antibiotic use.
As above it is known that oral antibiotics significantly disrupt
protective gut microflora, creating a favourable environment for
colonisation by opportunistic pathogens. Clostridium tetani is a
ubiquitous anaerobic bacillus that is known to produce a potent
neurotoxin. The normal site of binding for tetanus neurotoxin is the
spinal cord, yet the vagus nerve is capable of transporting tetanus
neurotoxin, providing a route of ascent from the intestinal tract to
the central nervous system and bypassing the spinal cord. The result
would be the typical symptoms of a tetanus infection would not be
evident. Once in the brain the tetanus neurotoxin disrupts the release
of neurotransmitters. This may explain the wide variety of behavioural
deficits apparent in autism. Bolte (1998) presents evidence of lab
animals exhibiting many of these behaviours after being injected in
the brain with tetanus neurotoxin, and also of children with autism
showing a significant reduction in sterotyped behaviour following
treatment with antimicrobials effective against intestinal clostridia.

Shaw (1999) has developed a similar technique to yeast metabolite
analysis by GC/MS for clostridia metabolites. While it has not been
fully identified it has been shown that tyrosine derivative, a
compound very similar but not identical to 3,4-dihydroyphenylpropionic
acid is raised in the urine of children with various conduct
disorders. It has also been pointed out that tyrosine, a substrate
used by the body for the production of neurotransmitters, might imply
that this unidentified product is important in altering key
biochemical pathways for neurotransmitters in the brain. The relevance
to autism remains unclear. Clearly a treatment to reduce the numbers
of clostridia in the gut might help to reduce the effects of this
inhabitation. However, clostridia are spore forming meaning
recolonisation is possible even after treatment. The relevance of
probiotic and prebiotic treatments has not been researched, yet this
appears a reasonable approach to aid suppression of the clostridia

Human Gut Flora and Gluten and Casein Intolerance in Autistic Children

Yeasts, including Candida albicans are known to secrete a number of
enzymes. These may include phospholipase, which will break down
phopholipids and proteases such as secretory aspartate protease which
break down proteins. These enzymes may partially digest the gut
membranes and lining itself. Furthermore, it is known that the
mycelium and chlamydospore are capable of tissue invasion (Nolting et
al, 1994). It is likely that such factors could increase the
permeability of the gut. This has important consequences in terms of
food absorption and digestion. In terms of autism symptoms this may be
highly relevant. It has been shown that incompletely broken down
portions of gluten and casein may be crossing the gut into the blood
and having an opioid effect in autistic children. Their symptoms being
a consequence of this opioid action (Reichelt, 1981; Shattock et al,
1990). While many mechanisms have been suggested for this incomplete
breakdown, it seems key that a yeast and/or clostridia overgrowth
would affect this in some way.


Products of the human gut microflora in relation to autism and its
symptoms appear to have been largely ignored in the past. However they
appear to be relevant certainly in terms of yeast and clostridia
species. Abnormal bacterial metabolites of tyrosine appear to be
elevated in autism and this seems related largely to an overgrowth in
clostridia species. Treatments to control this have resulted in
significant clinical improvement or complete remission of symptoms in
some cases. The issue of whether probiotic and prebiotic treatments
are relevant, needs to be researched. Elevation of yeast metabolites
such as tartaric acid and arabinose appears to be even more common in
autism. The arabinose appears to be involved in abnormal protein
binding which may adversely affect neuron connection and this may have
relevance to the appearance of autistic symptoms. Given the
intolerance autistic children appear to have to gluten and casein, an
involvement of arabinose may be important. However, the exact
biochemical role of arabinose remains unclear. Tartaric acid from the
yeast overgrowth may have a direct toxic effect on the muscles and is
a key inhibitor of the Krebs Cycle that supplies raw materials for
gluconeogenesis. The implications of this appear to be detrimental to
autistic function.

While it is clear that abnormal metabolites from the human gut flora
may contribute to autistic symptoms, it is certain that many other
systems and pathways are involved. It is possible that many are
functioning simultaneously but at varying levels between individuals.
This may give rise to the differences in symptoms exhibited by
sufferers. This may also explain the similarity of autism and other
chronic behavioural disorders such as Asperger Syndrome, PDD, ADHD,
ADD and Rett syndrome. While other pathways may exist, research into
the role of human gut flora and the full identification of species
involved may allow for more directed treatments. While it will not
cure the disorder, modifications of gut flora function might improve
symptoms significantly.

* The Childhood Autism Rating Scale, an observational measure of
various aspects of autism, for the child in question decreased from 43
(severely autistic) prior to introduction of these therapies to a
value of 29 (non-autistic) after therapy.


[ Auf dieses Posting antworten ]